Search hospitals > Texas > Amarillo
The Don and Sybil Harrington Cancer Center
Claim this profileAmarillo, Texas 79106
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
91 reported clinical trials
4 medical researchers
Summary
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 200 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Brian T. Pruitt, Daniel Arsenault, and Jeffery D. Hanrahan.Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Lung Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Anita RavipatiThe Don and Sybil Harrington Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Lung Cancer
27 reported clinical trials
52 drugs studied
Brian T. PruittThe Don and Sybil Harrington Cancer Center5 years of reported clinical research
Studies Breast Cancer
Studies Cancer
2 reported clinical trials
4 drugs studied
Daniel ArsenaultThe Don and Sybil Harrington Cancer Center10 years of reported clinical research
Studies Breast Cancer
2 reported clinical trials
6 drugs studied
Jeffery D. HanrahanThe Don and Sybil Harrington Cancer Center7 years of reported clinical research
Studies Ovarian Tumors
Studies Testicular Carcinoma
1 reported clinical trial
5 drugs studied
Clinical Trials running at The Don and Sybil Harrington Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Rectal Cancer
Cancer
Ovarian Tumors
Lung Adenocarcinoma
Colorectal Cancer
Testicular Carcinoma
Ovarian Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Don and Sybil Harrington Cancer Center?
The Don and Sybil Harrington Cancer Center is a medical facility located in Amarillo, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. The Don and Sybil Harrington Cancer Center is involved with conducting 91 clinical trials across 200 conditions. There are 4 research doctors associated with this hospital, such as Anita Ravipati, Brian T. Pruitt, Daniel Arsenault, and Jeffery D. Hanrahan.